IRadimed (Germany) Market Value
| 46K Stock | EUR 86.50 2.50 2.98% |
| Symbol | IRadimed |
IRadimed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IRadimed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IRadimed.
| 01/21/2025 |
| 01/16/2026 |
If you would invest 0.00 in IRadimed on January 21, 2025 and sell it all today you would earn a total of 0.00 from holding IRadimed or generate 0.0% return on investment in IRadimed over 360 days. IRadimed is related to or competes with ARDAGH METAL, Safety Insurance, FIREWEED METALS, Ping An, Jacquet Metal, Goosehead Insurance, and Reinsurance Group. IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging compatible medical devi... More
IRadimed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IRadimed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IRadimed upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.39 | |||
| Information Ratio | 0.1706 | |||
| Maximum Drawdown | 9.5 | |||
| Value At Risk | (3.18) | |||
| Potential Upside | 3.16 |
IRadimed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRadimed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IRadimed's standard deviation. In reality, there are many statistical measures that can use IRadimed historical prices to predict the future IRadimed's volatility.| Risk Adjusted Performance | 0.1625 | |||
| Jensen Alpha | 0.4316 | |||
| Total Risk Alpha | 0.154 | |||
| Sortino Ratio | 0.144 | |||
| Treynor Ratio | 3.83 |
IRadimed Backtested Returns
IRadimed appears to be very steady, given 3 months investment horizon. IRadimed holds Efficiency (Sharpe) Ratio of 0.33, which attests that the entity had a 0.33 % return per unit of risk over the last 3 months. By examining IRadimed's technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please utilize IRadimed's Downside Deviation of 2.39, market risk adjusted performance of 3.84, and Risk Adjusted Performance of 0.1625 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, IRadimed holds a performance score of 25. The company retains a Market Volatility (i.e., Beta) of 0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IRadimed's returns are expected to increase less than the market. However, during the bear market, the loss of holding IRadimed is expected to be smaller as well. Please check IRadimed's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether IRadimed's current trending patterns will revert.
Auto-correlation | -0.23 |
Weak reverse predictability
IRadimed has weak reverse predictability. Overlapping area represents the amount of predictability between IRadimed time series from 21st of January 2025 to 20th of July 2025 and 20th of July 2025 to 16th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IRadimed price movement. The serial correlation of -0.23 indicates that over 23.0% of current IRadimed price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 113.24 |
IRadimed lagged returns against current returns
Autocorrelation, which is IRadimed stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting IRadimed's stock expected returns. We can calculate the autocorrelation of IRadimed returns to help us make a trade decision. For example, suppose you find that IRadimed has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
IRadimed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If IRadimed stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if IRadimed stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in IRadimed stock over time.
Current vs Lagged Prices |
| Timeline |
IRadimed Lagged Returns
When evaluating IRadimed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of IRadimed stock have on its future price. IRadimed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, IRadimed autocorrelation shows the relationship between IRadimed stock current value and its past values and can show if there is a momentum factor associated with investing in IRadimed.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in IRadimed Stock
IRadimed financial ratios help investors to determine whether IRadimed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IRadimed with respect to the benefits of owning IRadimed security.